Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OE4F
|
|||
| Drug Name |
Imatinib and nilotinib derivative 1
|
|||
| Synonyms |
PMID30074415-Compound-22
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cas mediated disorder [ICD-11: N.A.] | Patented | [1] | |
| Company |
UNIVERSITY OF TAMPERE SUPURAN, Claudiu PARKKILA, Seppo
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H29N7O
|
|||
| Canonical SMILES |
CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)NC4=NC=CC(=N4)C5=CN=CC=C5
|
|||
| InChI |
1S/C28H29N7O/c1-34-14-16-35(17-15-34)20-21-7-9-22(10-8-21)27(36)31-24-5-2-6-25(18-24)32-28-30-13-11-26(33-28)23-4-3-12-29-19-23/h2-13,18-19H,14-17,20H2,1H3,(H,31,36)(H,30,32,33)
|
|||
| InChIKey |
JHMBUEWQJDGKGS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carbonic anhydrase (CA) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Carbonic anhydrase (CA) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).Expert Opin Ther Pat. 2018 Oct;28(10):729-740. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.